Wai-Yip Lee
Direktor/Vorstandsmitglied bei Aptorum Therapeutics Ltd.
Profil
Wai-Yip Lee is currently a Director at Aptorum Therapeutics Ltd.
He previously held positions as the Chief Executive Officer & Chief Scientific Officer at Aptorum Therapeutics Ltd.
from 2018 to 2019, Senior Scientist at Celgene Corp.
from 2008 to 2013, Principal Scientist at Novartis Pharmaceuticals Corp.
from 2003 to 2008, and Assistant Professor at The Chinese University of Hong Kong from 2013 to 2018.
Dr. Lee is also currently the Head-Research & Development at Aptorum Group Ltd.
from 2019 to 2023.
Dr. Lee obtained a doctorate degree from the University of Wisconsin in 2003 and an undergraduate degree from The Chinese University of Hong Kong in 1995.
Aktive Positionen von Wai-Yip Lee
| Unternehmen | Position | Beginn |
|---|---|---|
Aptorum Therapeutics Ltd.
 Aptorum Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Aptorum Therapeutics Ltd. manufactures pharmaceutical products. The company is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Wai-Yip Lee
| Unternehmen | Position | Ende |
|---|---|---|
| APTORUM GROUP LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2023 |
Aptorum Therapeutics Ltd.
Aptorum Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Aptorum Therapeutics Ltd. manufactures pharmaceutical products. The company is headquartered in Hong Kong. | Vorstandsvorsitzender | 01.03.2019 |
| The Chinese University of Hong Kong | Corporate Officer/Principal | 01.01.2018 |
| CELGENE | Corporate Officer/Principal | 01.07.2013 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.11.2008 |
Ausbildung von Wai-Yip Lee
| The Chinese University of Hong Kong | Undergraduate Degree |
| University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APTORUM GROUP LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Aptorum Therapeutics Ltd.
Aptorum Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Aptorum Therapeutics Ltd. manufactures pharmaceutical products. The company is headquartered in Hong Kong. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
